Korean J Med.  2002 Mar;62(3):293-296.

A case of thymic hyperplasia after high-dose chemotherapy in a patient with malignant lymphoma

Affiliations
  • 1Department of Internal Medicine, The Catholic University College of Medicine, Seoul, Korea.
  • 2Department of Radiology, The Catholic University College of Medicine, Seoul, Korea. swsong@cmc.cuk.ac.kr.

Abstract

Thymic hyperplasia results from thymic regrowth after atrophy during a stressful period. Differentiation from recurrent or residual neoplasm may be an important consideration. Thymic hyperplasia is most problematic when it is observed in patients with malignant lymphoma. We report a case of thymic hyperplasia in which thymic enlargement is developed in a malignant lymphoma patient with high-dose chemotherapy and autologous peripheral blood stem cell transplantation and this condition is confirmed by the findings of serial chest computed tomography without chemotherpy.

Keyword

Thymic hyperplasia; Malignant lymphoma; Computed tomography

MeSH Terms

Atrophy
Drug Therapy*
Humans
Lymphoma*
Neoplasm, Residual
Peripheral Blood Stem Cell Transplantation
Thorax
Thymus Hyperplasia*
Full Text Links
  • KJM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr